UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000027678
Receipt No. R000031705
Scientific Title Clinical study of blood purification therapy in critical care in Japan: Results from the survey research of the Japan Society for Blood Purification in Critical Care in 2013
Date of disclosure of the study information 2017/06/07
Last modified on 2017/06/07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Clinical study of blood purification therapy in critical care in Japan: Results from the survey research of the Japan Society for Blood Purification in Critical Care in 2013
Acronym The survey research of the Japan Society for Blood Purification in Critical Care in 2013
Scientific Title Clinical study of blood purification therapy in critical care in Japan: Results from the survey research of the Japan Society for Blood Purification in Critical Care in 2013
Scientific Title:Acronym The survey research of the Japan Society for Blood Purification in Critical Care in 2013
Region
Japan

Condition
Condition Diseases treated with blood purification therapy
Classification by specialty
Medicine in general Nephrology Surgery in general
Emergency medicine Intensive care medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To clarify the current status of blood purification therapy in critical care in Japan
Basic objectives2 Others
Basic objectives -Others To clarify the survival rate of the patients treated with blood purification therapy
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The number of the patients treated with blood purification, diseases needed for blood purification therapy, and survival rate
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria The patients treated with blood purification therapy between January 1 and December 31 2012.
Key exclusion criteria aged <20 years old, and those whose records regarding date of birth, mode of blood purification therapy, primary disease, or outcome were incomplete
Target sample size 2000

Research contact person
Last name of lead principal investigator
1st name
Middle name
Last name Japan Society for Blood Purification in Critical Care
Organization The Survey Committee
Division name The Survey Committee
Zip code
Address 2F, 2-27-18, Hongo, Bunkyo-ku, Tokyo, Japan
TEL 03-3811-8210
Email abe.masanori@nihon-u.ac.jp

Public contact
1st name of contact person
1st name
Middle name
Last name Masanori Abe
Organization Japan Society for Blood Purification in Critical Care
Division name The survey committee
Zip code
Address 2F, 2-27-18, Hongo, Bunkyo-ku, Tokyo, Japan
TEL 03-3811-8210
Homepage URL
Email abe.masanori@nihon-u.ac.jp

Sponsor
Institute The Survey Committee, Japan Society for Blood Purification in Critical Care
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 06 Month 07 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2011 Year 10 Month 23 Day
Date of IRB
Anticipated trial start date
2013 Year 01 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Data covered 2279 patients who were treated with blood purification therapy in the intensive care unit of 43 facilities in Japan

Management information
Registered date
2017 Year 06 Month 07 Day
Last modified on
2017 Year 06 Month 07 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031705

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.